Figure 4. . Quantification of the deposited poly lactic-co-glycolic acid-SCD-19 nanoparticles.

Mass distribution of nebulized nanoparticles using a Next Generation Impactor, Model 170. Data were expressed as the percentage of total drug deposited on all stages of the impactor including the throat and was represented by the mean ± standard deviation. The data are represented as mass percentage of nominal dose (n = 3).